Ariel Danielle Hodges, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 881 Prosperity School Rd, Rock, WV 24747 Phone: 304-921-8378 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.
Despite uncertain economic environment, Russia still represents a promising healthcare market with strong potential for further growth.
A review of more than 100 studies found overweight girls tend to reach puberty earlier than their peers do.
The Partnership for Quality Home Healthcare — a coalition of home health providers dedicated to developing innovative reforms to improve the program integrity, quality, and efficiency of home healthcare for our nation's seniors — today commended the Centers for Medicare and Medicaid Services for extending safeguards designed to protect Medicare beneficiaries, prevent fraudulent behavior and save taxpayer dollars.
Oncolytics Biotech Inc. today announced that it has been granted its 33rd U.S. Patent, # 7,608,257, entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus." The patent claims cover methods of using reovirus in combination with currently approved chemotherapeutic agents to treat patients that are refractory to those chemotherapeutic agents alone.
› Verified 1 days ago